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Kinetics of radioiodinated heptadecanoic acid and
metabolites in the normal and ischaemic canine heart
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This study was undertaken to elucidate if the myocardial elimination rate of the radioactivity after
administration of radioiodinated heptadecanoic acid was related to beta-oxidation of the fatty acid or related to
washout of free radioiodide. In samples of normal and ischaemic myocardium the distribution of the
radioactivity over free radioiodide, heptadecanoic acid and lipids was determined. In normal myocardium the
major component was free radioiodide, only a small percentage being heptadecanoic acid. In ischaemic
myocardium more radiolabelled lipids were present and less free iodide when compared with normal
myocardium. The percentage heptadecanoic acid was slightly increased.
// is concluded that radioiodinated heptadecanoic acid behaves like the natural analogues regarding uptake
and distribution. However, washout of free radioiodide determines the elimination rate as observed during a
scintigraphic study.
Introduction
Oxidation of long-chain free fatty acids (FFAs)
contributes under normal physiological conditions
for about 80% to the production of energy-rich
phosphate bonds. In contrast, in ischaemia uptake
and degradation of FFA is diminished. Hence, FFAs
labelled with a radioisotope, can be used for cardiac
imaging and for in vivo investigation of myocardial
lipid metabolism. One of these fatty acids is
heptadecanoic acid labelled with radioiodine in the
omega position (I-HDA). With this agent, scinti-
graphic images can be obtained, clearly distin-
guishing between normal and ischaemic or
infarcted myocardium""3 ' .
The elimination of the radioactivity from the
myocardium is used as indicator of myocardial
metabolism. A few arguments favour this concept: in
ischaemic myocardium the rate of elimination is
delayed when compared with normal myocardium'4'.
Simultaneous administration with glucose-insuline
also decreases the rate of elimination'3', demon-
strating the effect of substrate availability in
myocardial metabolism. Other data, however, sug-
gest that the elimination rate is not closely related to
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fatty acid metabolism but merely related to washout
of the radiolabel, being split off during beta-
oxidation16' of the carbon chain.
The aim of this study was to establish the relation
between the elimination rate and I-HDA meta-
bolism. We did so by analysing in normal and
ischaemic myocardium the content of I-HDA, its
metabolite free radioiodide and the various radio-
labelled lipids.
Material and methods
PREPARATION OF I-13 1-HEPTADECANOIC ACID
I-HDA was prepared by non-isotopic halogen
exchange using 17-bromo-HDA as the parent
compound. Free iodide was removed by eluation
over Sephadex A25. I-HDA was dissolved in a
minimal volume of ethanol and physiological saline
and added to 20% HSA. The final solution
contained less than 5% ethanol.
ANIMAL EXPERIMENTS
Twelve male mongrel dogs were studied after
overnight fasting (weight between 21 and 35 kg).
Dogs were anaesthetized with 30 mg kg"1 sodium
pentobarbital i.v. after premedication with atropine
(0-5 mg), droperidol (2-5 mg) and fentanyl (0-05 mg).
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Anaesthesia was maintained with nitrous oxide and
oxygen in combination with trifluoroethane 2%.
Pulrponary ventilation was maintained with Pul-
monat' positive pressure respirator. A catheter was
placed in a carotid artery for arterial pressure
measurements and blood sampling.
Electrocardiograms were monitored continuously.
Three groups of dogs were studied:
group 1—6 dogs without a coronary occlusion;
group -2—3 dogs with a coronary occlusion for a
period of 5 min;
group 3—3 dogs with a coronary occlusion for a
period of 6 h.
The chest was opened by an incision through the
fifth left intercostal space, the pericardium opened
and fixed to the chest wall to form a pericardial
craddle. Dogs of groups 2 and 3 underwent
occlusion of the anterior descending branch (LAD)
of the left coronary artery, just distal to the first
diagonal branch.
In all dogs, 3 to 9 mCi I-HDA was rapidly
injected into the left atrium: in dogs of group 1 this
was after exposing the heart, in dogs of groups 2 and
3 this was after the coronary occlusion period.
In dogs of group 1 serial biopsies were taken with
a fast spinning, hollow needle (bore 2-11 mm) from
myocardium perfused by the LAD (weight between
15 and 50 mg). These biopsies were rapidly stored in
liquid nitrogen. Samples were taken at approxi-
mately 1, 2, 5, 10, 20 and 30 min after I-HDA
injection. Dogs of groups 2 and 3: 5 min after
injection of I-HDA 30 ml iced KC1 solution was
injected into the left ventricle. Simultaneously liquid
nitrogen was poured over the heart, which was then
rapidly excised. The heart was immersed in iced
water and washed to remove blood. From injection
of KC1 to immersion in water took less than 40 s.
From the ischaemic myocardium, perfused by the
LAD, three pieces of myocardium were excised,
measuring approximately 1 x 1 cm. From an area
perfused by the left circumflex artery three pieces of
the same size were taken.
All samples of the dogs were weighed and counted
in a gamma well counter (LKB Ultrogamma 1280),
using a window setting suitable for the 1-131
isotope. Count time for biopsies of group 1 dogs was
2 min, for those of group 2 and 3 1 min.
BLOODSAMPLING
In dogs of group I 2 ml bloodsamples were drawn
from the arterial catheter, at the same time the
biopsies were taken.
CHEMICAL ANALYSIS
Myocardial biopsies
After freezing, myocardial biopsies were ground in
a mortar. During pulverization 2 ml of chloro-
form/methanol 2/1 v.v. was added. After addition of
002 N HO, I ml 48% urea and after being
centrifuged, the aqueous fraction containing the free
radioiodide, the pellet and the organic fraction
containing I-HDA and lipids were separated. The
latter fraction was dried by evaporation under a
stream of nitrogen until a minimal volume was left.
The solution containing the lipid fraction was
brought onto a silicagel chromatography plate
(Merck 60 F 254) by use of the eluent
hexane/ether/acetic acid 80/20/1 v.v. On the
chromatography plate I-HDA was identified by
comparison with a standard under fluorescence.
Approximate Rf values: phospholipids 00, I-HDA,
0-50, (mono, di, tri)-glycerides between 0-60 and 0-90
and cholesterol esters 0-95. I-HDA was isolated by
cutting the chromatography plate in appropriate
strips. The strips of the fatty acid esters were
combined and will be further referred to as 'lipids'.
Count rates of the aqueous fraction—containing the
free radioiodide—, of I-HDA and of the radio-
labelled lipids were obtained in the gamma well
counter. Count time was 3 min per sample.
Corrections were made for physical decay.
Bloodsamples
The plasma was separated from the haematocrit
by centrifugation. Two hundred microliter plasma
was eluated over Sephadex A25, which retained the
free radioiodide. The eluent contained the I-HDA.
The Sephadex column and the eluent were counted
in the gamma well counter. Count time was 3 min,
and was corrected for decay of the radioisotope.
DATA ANALYSIS
Myocardial biopsies
Count rates of a biopsy obtained prior to chemical
analysis were expressed as cpm mg~l. After
chemical analysis the count rates of the separate
fractions of a biopsy were added. The fractions were
expressed as a percentage of the cpm mg"1 of the
biopsy obtained prior to pulverization.
Bloodsamples
Total plasma activity was expressed as a percent-
age of the plasma sample with the highest counts in
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Table I Dogs of group 1: count rales in myocardial biopsies
as a percentage of the maximal count rate
Total
mean
SD
I-HDA
mean
SD
Free iodide
mean
SD
I-lipids
mean
SD
1
71
6
9
8
46
13
16
2
2
82
8
6
2
55
19
21
5
Time
5
97
4
4
1
65
17
28
6
(min)
10
85
12
2
1
51
15
32
7
20
70
16
1
1
35
11
34
7
30
71
19
1
1
29
6
40
8
100
80
60
£ 40
20 I
I
!
I
i
I Free
I iodide
| | I-HOA
I-hpids
Normol ischaemic
Group 2
Figure 1 Distribution of radioactivity
ischaemic myocardium in dogs after a
Normal ischaemic
Group 3
in normal and
5 min and 6 h
occlusion period of the LAD. The proportion of free
radioiodide (I~), I-HDA and radioiodinated lipids are
given.
a dog. The aqueous and organic fractions were
expressed as a percentage of total plasma activity.
Results
Arterial blood pressure in dogs decreased from
85/62 to 74/60 mmHg during the study.
Table 1 gives the time course of the radioactivity,
and the distribution over I-HDA, free iodide, and
the radioiodinated lipids in dogs of group 1. Total
count rates as obtained prior to chemical work-up
increased up to the 5th min, and thereafter were seen
to decrease. The half-time value calculated from the
5th to the 30th min was 37 min. I-HDA rapidly
decreased from the onset of the study. Free
radioiodide was the largest part of the radioactivity
and the course paralleled the curve of the total
radioactivity. Lipids increased during the study.
Table 2 and Fig. 1 show the count rates of normal
and ischaemic myocardium 5 min after injection of
I-HDA in dogs of groups 2 and 3.
In normal myocardium the distribution of the
radioactivity was the same as in dogs of group 1 at
5 min: the major part of the radioactivity originated
from free iodide and lipids, a small percentage being
I-HDA. In ischaemic myocardium the percentage I-
HDA was slightly higher, free iodide, predominantly
present in normal myocardium, was less and lipids
contributed most to the radioactivity. No statistical
significant difference was observed between dogs
with a 5 min (group 2) and dogs with a 6 h occlusion
period (group 3). Figure 2 shows the course of
Table 2 Dogs of groups 2 and 3: count rales in normal and ischaemic
myocardium 5 min after I-HDA administration
I-HDA
mean
SD
Free iodide
mean
SD
I-lipids
mean
SD
Group 2
normal
2
1
71
22
27
22
ischaemic
6
5
39
6
55
18
Group 3
normal
7
3
69
5
24
3
ischaemic
12
6
41
9
47
10
100 F. C. Visser et al.
75
50
8
a.
25
1 Total activity
2 Fatty acids
3 Iodide
Time (mm)
Figure 2 Time course of the radioactivity in blood in
normal dogs during 30 min. Data are expressed as a
percentage of the counts of the first blood sample.
Separation of the radioactivity in I-HDA and I" is given.
NORMAL DOGS
The increase in total radioactivity of the biopsies
(Table 1) was due to uptake of recirculating I-HDA
in arterial blood (Fig. 2). In the serial myocardial
biopsies I-HDA rapidly decreased to low levels,
whereas lipids slightly increased during the study.
The major part of the radioactivity consisted of free
radioiodide which paralleled the course of the total
radioactivity (Table 1). The data indicate that after
entering the cell I-HDA is either stored in lipids or
oxidized, releasing free radioiodide, thus showing a
behaviour similar to the 'natural' fatty acids. The
results suggest that oxidation rate is a very fast
process and—as the lipids remained constant from
the 5th until the 30th min—that the washout of
radioiodide from the myocardial cell into the
circulation determines the elimination rate as
observed during a scintigraphic study.
radioactivity in plasma in group 1 dogs. In the first
10 min-a rapid decrease was seen followed by a
plateau phase. In the first minutes the major
component was I-HDA: mean half-life of I-HDA of
group 1 dogs was 2-4 min. After 20 min almost
100% of the radioactivity was radioiodide.
Discussion
Radiolabelled FFAs are used to explore non-
invasively myocardial fatty acid metabolism in men.
C-l 1-palmitic acid is the standard used to quantify
in vivo fatty acid metabolism in normal and
pathologically altered myocardium; however, the
high costs of production and detection facilities limit
the general use of these tracers. One of the
commonly used alternatives is heptadecanoic acid
labelled with the gamma emitter radioiodine in the
omega position. As the iodide molecule structurally
resembles a methyl group, minimal stearic hindrance
is present, which theoretically gives a behaviour
identical to the natural fatty acid analogue.
The elimination of the radioactivity is supposed to
reflect cardiac oxidative metabolism of the fatty
acids because radioiodide is split off during beta-
oxidation<7). After being split off, iodide leaves the
cell and enters the circulation. This oxidative
concept is supported by the fact that glucose
infusion and ischaemic conditions delay the rate of
elimination.
This study was undertaken to ascertain whether
the elimination rate was related to oxidative
metabolism or to washout of free radioiodide.
ISCHAEMIC DOG MYOCARDIUM
In an ischaemic myocardium, FFA metabolism is ^
markedly altered. Uptake and metabolic breakdown
of FFAs is decreased and a larger fraction of FFAs
is stored in various lipids(8). The same pattern was
seen in our experiments (Fig. 1 and Table 2):
compared with normal myocardium a larger part of >
the radioactivity was present in the lipids. The
contribution of free iodide was seen to decreased,
which indicated that the oxidation of I-HDA was M
diminished.
Although I-HDA was administered in group 2
dogs after 5 min and in group 3 dogs after 6 h no
difference in metabolic pattern was observed
between the two groups in the ischaemic myocar-
dium. For the group 3 dogs, one may speculate that
uptake and metabolism of I-HDA occurred only in '"*
the ischaemic cells and not in the necrotic cells. This
would give the same results as for group 2 dogs.
In summary: the metabolic behaviour of I-HDA
with regard to uptake and distribution in normal
and ischaemic myocardium resembles that of the
naturally occurring fatty acids. Furthermore, the ,
elimination rate of the radioactivity as observed
during a scintigraphic study cannot be related to the
rate of beta-oxidation of I-HDA. In contrast,
washout of free radioiodide from the myocardial cell
into the circulation determines the elimination rate
during the studied time period. Alterations in the
elimination rate must therefore be interpreted as ^
changes in the iodide concentration gradient and
altered membrane function as barriers for iodide
washout. Alterations in intracellular iodide con-
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centration can be caused by decreased I-HDA
uptake and oxidation, or increased storage in the
lipids (e.g. under influence of ischaemia and glucose
administration). Membrane properties can change
during ischaemia and infarction or during phar-
macological interventions (halothane anaesthesia).
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